Trials / Completed
CompletedNCT03156270
Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction
A Prospective, Non-Randomized Study to Evaluate Treatment Outcome of Nasal Airway Obstruction Using the Aerin Medical Vivaer™ Stylus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Aerin Medical · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates subjective and objective measures of treatment outcome after using the Aerin Medical Vivaer™ Stylus to treat nasal obstruction
Detailed description
This is a non-significant risk, prospective, non-randomized study to evaluate subjective and objective measures of nasal obstruction both before and after treatment with the Vivaer Stylus. The Stylus is used to deliver radiofrequency (RF) energy to the nasal valve area to improve symptoms in those diagnosed with nasal airway obstruction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vivaer Stylus | Stylus used to deliver low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area |
Timeline
- Start date
- 2017-09-19
- Primary completion
- 2019-07-12
- Completion
- 2019-08-06
- First posted
- 2017-05-17
- Last updated
- 2021-06-16
- Results posted
- 2021-06-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03156270. Inclusion in this directory is not an endorsement.